Chesterfield, MO, United States of America

Balekudru Devadas

This inventor holds 68 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Compounds (CPC class A61K). Top assignees: G.d. Searle & Company, Pharmacia Corporation, Confluence Life Sciences, Inc.. Active years: 1992-2020.

USPTO Granted Patents = 68 (Patent Applications = 3)

% Patents Active = 48.5

CIPO Patents = 2 (Patent Applications = 11)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 7.6

ph-index = 10

Forward Citations = 908(Granted Patents)

Forward Citations (Not Self Cited) = 845(Dec 10, 2025)

Inventors with similar research interests:

Location History:

St. Louis, MO (US) (1994 - 1995)
Chestefield, MO (US) (1998)
Chesterfield, MO (US) (1992 - 2020)

Company Filing History:

39 out of 1,323

G.d. Searle & Company

patents

12 out of 220

Pharmacia Corporation

patents

7 out of 12

Confluence Life Sciences, Inc.

Washington University

Pharmacia Corporation (of Pfizer, Inc.)

patents

Years Active: 1992-2020

Loading Chart...

Areas of Expertise:

Bruton's Tyrosine Kinase

Retroviral Protease Inhibitors

Integrin Antagonists

Pyridinone Compounds

Sulfonamide Derivatives

Cyclooxygenase Inhibitors

Heterocyclic Compounds

Inflammation Treatment

Disease Treatment

Pyrimidinone Compounds

Amino Acid Derivatives

Pyridinyl Compounds

68 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10815213 - Bruton's tyrosine kinase inhibitors (2020-10-27),

2. 10266513 - Bruton's tyrosine kinase inhibitors (2019-04-23),

3. 9505765 - 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment (2016-11-29),

4. 9365547 - Substituted pyridinone-pyridinyl compounds (2016-06-14),

5. 9365546 - Substituted pyridinone-pyridinyl compounds (2016-06-14),

6. 9359300 - Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds (2016-06-07),

7. 9056110 - Substituted pyrimidinone-phenyl-pyrimidinyl compounds (2015-06-16),

8. 8563558 - Substituted pyridine urea compounds (2013-10-22),

9. 8507499 - Substituted indole/indazole-pyrimidinyl compounds (2013-08-13),

10. 7629363 - Diaryl substituted pyridinones (2009-12-08),

11. 7339078 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2008-03-04),

12. 7161033 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2007-01-09),

13. 7141594 - Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2006-11-28),

14. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation (2006-11-21),

15. 7119098 - Heteroarylakanoic acids as intergrin receptor antagonists (2006-10-10),

Title: Inventor Balekudru Devadas

Introduction: Balekudru Devadas is a renowned inventor based in Chesterfield, Missouri. He is known for his groundbreaking innovations in various fields.

Latest Patents: Balekudru Devadas holds several patents in the areas of technology, healthcare, and sustainable energy. His most recent patents focus on improving renewable energy sources and enhancing medical devices.

Career Highlights: With a career spanning over two decades, Balekudru Devadas has worked with leading research institutions and companies to bring his inventions to life. He has a proven track record of turning innovative ideas into successful products.

Collaborations: Throughout his career, Balekudru Devadas has collaborated with top engineers, scientists, and designers to push the boundaries of technology. His partnerships have led to the development of cutting-edge solutions that have made a significant impact in the industry.

Conclusion: Balekudru Devadas continues to be a driving force in the world of innovation, with his passion for creating transformative technologies that shape the future. His dedication to excellence and creativity sets him apart as a visionary inventor.